What Is Letybo? The New Botulinum Toxin for Frown Lines Explained
In this concise educational monologue, board‑certified dermatologist Dr. Jane Yoo introduces Letibo (also referred to as Letybo), a newly U.S.‑approved botulinum toxin formulation specifically indicated for moderate‑to‑severe glabellar (frown) lines. She explains that Letibo contains purified lechebotulinum A, which temporarily relaxes the corrugator and procerus muscles that create dynamic wrinkles, smoothing the eleven lines between the brows. Dr. Yoo highlights its extensive international track record—being the leading neuromodulator in South Korea and approved in more than 65 countries—before summarizing pivotal multi‑center clinical trial data: patients can see improvement as early as day 1, most notice results within three days, and effects typically last up to 16 weeks, comparable to other leading products. Safety findings show a low 0.5 % incidence of eyelid ptosis and no neutralizing antibodies detected. She emphasizes that outcomes depend on proper dosing, injection technique, and individual anatomy, urging viewers to seek qualified injectors who can tailor treatment to each patient’s facial dynamics.
